The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Evidence-Based Medical Management of Peripheral Artery Disease
Open accessAbstract
Peripheral artery disease is an atherosclerotic disease of the lower extremities associated with high cardiovascular mortality. Management of this condition may include lifestyle modifications, medical management, endovascular repair, or surgery. The medical approach to peripheral artery disease is multifaceted and includes cholesterol reduction, antiplatelet therapy, anticoagulation, peripheral vasodilators, blood pressure management, exercise therapy, and smoking cessation. Adherence to this regimen can reduce limb-related complications like critical limb ischemia and amputation, as well as systemic complications of atherosclerosis like stroke and myocardial infarction. Relative to coronary artery disease, peripheral artery disease is an undertreated condition. In this article, we explore the evidence behind medical therapies for the management of peripheral artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Long-term use of ticagrelor in patients with prior myocardial infarction
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500857 · Cited by 1,999
Effects of aspirin for primary prevention in persons with diabetes mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804988 · Cited by 1,200
Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32458-3 · Cited by 754
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
Hiatt, W. R., Fowkes, F. G. R., Heizer, G., Berger, J. S., Baumgartner, I., Held, P., Katona, B. G., Mahaffey, K. W., Norgren, L., Jones, W. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611688 · Cited by 636
Fowkes, F. G. R. (2010) · JAMA · doi:10.1001/jama.2010.221 · Cited by 624
Ethnic-Specific Prevalence of Peripheral Arterial Disease in the United States
Allison, M. A., Ho, E., Denenberg, J. O., Langer, R. D., Newman, A. B., Fabsitz, R. R., & Criqui, M. H. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.12.010 · Cited by 574
Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514
Peripheral Arterial Disease: Morbidity and Mortality Implications
Golomb, B. A., Dang, T. T., & Criqui, M. H. (2006) · Circulation · doi:10.1161/circulationaha.105.593442 · Cited by 498
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa065959 · Cited by 442
Ethnicity and Peripheral Arterial Disease: The San Diego Population Study
Criqui, M. H., Vargas, V., Denenberg, J. O., Ho, E., Allison, M., Langer, R. D., Gamst, A., Bundens, W. P., & Fronek, A. (2005) · Circulation · doi:10.1161/circulationaha.105.546507 · Cited by 332
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia
Narula, N., Dannenberg, A. J., Olin, J. W., Bhatt, D. L., Johnson, K. W., Nadkarni, G., Min, J., Torii, S., Poojary, P., Anand, S. S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.002 · Cited by 326
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
Östergren, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.033 · Cited by 324
Allison, M. A., Criqui, M. H., McClelland, R. L., Scott, J. M., McDermott, M. M., Liu, K., Folsom, A. R., Bertoni, A. G., Sharrett, A. R., Homma, S., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.049 · Cited by 257
Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease
Arya, S., Khakharia, A., Binney, Z. O., DeMartino, R. R., Brewster, L. P., Goodney, P. P., & Wilson, P. W. F. (2018) · Circulation · doi:10.1161/circulationaha.117.032361 · Cited by 257
Patnode, C. D., Henderson, J. T., Thompson, J. H., Senger, C. A., Fortmann, S. P., & Whitlock, E. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0171 · Cited by 238
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
Murphy, S. A., Cannon, C. P., Blazing, M. A., Giugliano, R. P., White, J. A., Lokhnygina, Y., Reist, C., Im, K., Bohula, E. A., Isaza, D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.077 · Cited by 205
Atherothrombotic risk stratification and ezetimibe for secondary prevention
Bohula, E. A., Morrow, D. A., Giugliano, R. P., Blazing, M. A., He, P., Park, J.-G., Murphy, S. A., White, J. A., Kesaniemi, Y. A., Pedersen, T. R., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.070 · Cited by 204
Armstrong, E. J., Wu, J., Singh, G. D., Dawson, D. L., Pevec, W. C., Amsterdam, E. A., & Laird, J. R. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.08.064 · Cited by 202
Bavry, A. A., Anderson, R. D., Gong, Y., Denardo, S. J., Cooper-DeHoff, R. M., Handberg, E. M., & Pepine, C. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.142240 · Cited by 188
Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease
Berger, J. S., & Ladapo, J. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.064 · Cited by 183
Sabatine, M. S., Giugliano, R. P., Keech, A., Honarpour, N., Wang, H., Liu, T., Wasserman, S. M., Scott, R., Sever, P. S., & Pedersen, T. R. (2016) · American Heart Journal · doi:10.1016/j.ahj.2015.11.015 · Cited by 176
Influence of Race on the Management of Lower Extremity Ischemia: Revascularization vs Amputation
Durazzo, T. S., Frencher, S., & Gusberg, R. (2013) · JAMA Surgery · doi:10.1001/jamasurg.2013.1436 · Cited by 120
Soden, P. A., Zettervall, S. L., Deery, S. E., Hughes, K., Stoner, M. C., Goodney, P. P., Vouyouka, A. G., & Schermerhorn, M. L. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.06.089 · Cited by 112
Collins, T. C., Johnson, M., Henderson, W., Khuri, S. F., & Daley, J. (2002) · Medical Care · doi:10.1097/00005650-200201001-00012 · Cited by 103
Hsu, C.-Y., Chen, Y.-T., Su, Y.-W., Chang, C.-C., Huang, P.-H., & Lin, S.-J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3717 · Cited by 89
Racial/Ethnic Disparities in Amputation and Revascularization: A Nationwide Inpatient Sample Study
Hughes, K., Seetahal, S., Oyetunji, T., Rose, D., Greene, W., Chang, D., Cornwell, E., & Obisesan, T. (2014) · Vascular and Endovascular Surgery · doi:10.1177/1538574413510618 · Cited by 56
Statin use and lower extremity amputation risk in nonelderly diabetic patients
Sohn, M.-W., Meadows, J. L., Oh, E. H., Budiman-Mak, E., Lee, T. A., Stone, N. J., & Pearce, W. B. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.069 · Cited by 52
McDermott, M. M., Polonsky, T. S., Kibbe, M. R., Tian, L., Zhao, L., Pearce, W. H., Gao, Y., & Guralnik, J. M. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.02.037 · Cited by 36
Huen, K. H., Chowdhury, R., Shafii, S. M., Brewster, L. P., Arya, S., Duwayri, Y., Veeraswamy, R. K., Dodson, T. F., & Rajani, R. R. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.09.014 · Cited by 20
Peripheral Artery Disease and African Americans: Review of the Literature
Solaru, K. W. (2019) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-019-0621-1 · Cited by 6
Self-citation
Cited by
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Metadata
- Authors
- Bevan, G. H., & White Solaru, K. T.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2020-03
- Volume
- 40
- Issue
- 3
- Pages
- 541-553
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W3003770534
- Cited by
- 211
- References
- 46
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.